Search Results

There are 92067 results for: content related to: Exercise alleviates Parkinsonism: clinical and laboratory evidence

  1. You have free access to this content
    Pathogenesis of familial Parkinson’s disease: new insights based on monogenic forms of Parkinson’s disease

    Journal of Neurochemistry

    Volume 111, Issue 5, December 2009, Pages: 1075–1093, Taku Hatano, Shin-ichiro Kubo, Shigeto Sato and Nobutaka Hattori

    Version of Record online : 24 SEP 2009, DOI: 10.1111/j.1471-4159.2009.06403.x

  2. Cognitive dysfunction and depression in Parkinson’s disease: what can be learned from rodent models?

    European Journal of Neuroscience

    Volume 35, Issue 12, June 2012, Pages: 1894–1907, Hanna S. Lindgren and Stephen B. Dunnett

    Version of Record online : 19 JUN 2012, DOI: 10.1111/j.1460-9568.2012.08162.x

  3. You have full text access to this OnlineOpen article
    Genetic findings in Parkinson’s disease and translation into treatment: a leading role for mitochondria?

    Genes, Brain and Behavior

    Volume 7, Issue 2, March 2008, Pages: 129–151, V. Bogaerts, J. Theuns and C. Van Broeckhoven

    Version of Record online : 7 JUL 2007, DOI: 10.1111/j.1601-183X.2007.00342.x

  4. Basal ganglia activity patterns in parkinsonism and computational modeling of their downstream effects

    European Journal of Neuroscience

    Volume 36, Issue 2, July 2012, Pages: 2213–2228, Jonathan E. Rubin, Cameron C. McIntyre, Robert S. Turner and Thomas Wichmann

    Version of Record online : 17 JUL 2012, DOI: 10.1111/j.1460-9568.2012.08108.x

  5. You have free access to this content
    Neuropathology, biochemistry, and biophysics of α-synuclein aggregation

    Journal of Neurochemistry

    Volume 103, Issue 1, October 2007, Pages: 17–37, Vladimir N. Uversky

    Version of Record online : 10 JUL 2007, DOI: 10.1111/j.1471-4159.2007.04764.x

  6. Perspectives on recent advances in the understanding and treatment of Parkinson’s disease

    European Journal of Neurology

    Volume 16, Issue 10, October 2009, Pages: 1090–1099, A. H. Schapira, Y. Agid, P. Barone, P. Jenner, M. R. Lemke, W. Poewe, O. Rascol, H. Reichmann and E. Tolosa

    Version of Record online : 30 AUG 2009, DOI: 10.1111/j.1468-1331.2009.02793.x

  7. Moving from continuous dopaminergic stimulation to continuous drug delivery in the treatment of Parkinson’s disease

    European Journal of Neurology

    Volume 19, Issue 12, December 2012, Pages: 1502–1508, O. Gershanik and P. Jenner

    Version of Record online : 4 JAN 2012, DOI: 10.1111/j.1468-1331.2011.03593.x

  8. You have free access to this content
    Tracking extranigral degeneration in animal models of Parkinson’s disease: quest for effective therapeutic strategies

    Journal of Neurochemistry

    Volume 118, Issue 3, August 2011, Pages: 326–338, Varduhi H. Knaryan, Supriti Samantaray, Charlene Le Gal, Swapan K. Ray and Naren L. Banik

    Version of Record online : 17 JUN 2011, DOI: 10.1111/j.1471-4159.2011.07320.x

  9. Rotigotine transdermal patch for the treatment of Parkinson’s Disease

    Fundamental & Clinical Pharmacology

    Volume 27, Issue 1, February 2013, Pages: 81–95, Santiago Perez-Lloret, María Verónica Rey, Pietro Lucca Ratti and Olivier Rascol

    Version of Record online : 9 FEB 2012, DOI: 10.1111/j.1472-8206.2012.01028.x

  10. You have full text access to this Open Access content
    Cerebral correlates of psychotic syndromes in neurodegenerative diseases

    Journal of Cellular and Molecular Medicine

    Volume 16, Issue 5, May 2012, Pages: 995–1012, Kurt A. Jellinger

    Version of Record online : 25 APR 2012, DOI: 10.1111/j.1582-4934.2011.01311.x

  11. Neurotransmission in Parkinson’s disease: beyond dopamine

    European Journal of Neurology

    Volume 17, Issue 3, March 2010, Pages: 364–376, P. Barone

    Version of Record online : 30 DEC 2009, DOI: 10.1111/j.1468-1331.2009.02900.x

  12. Challenges to the development of disease-modifying therapies in Parkinson’s disease

    European Journal of Neurology

    Volume 18, Issue s1, March 2011, Pages: 16–21, A. H. V. Schapira

    Version of Record online : 24 JAN 2011, DOI: 10.1111/j.1468-1331.2010.03324.x

  13. You have free access to this content
    Mitochondrial alterations in Parkinson’s disease: new clues

    Journal of Neurochemistry

    Volume 107, Issue 2, October 2008, Pages: 317–328, Miquel Vila, David Ramonet and Celine Perier

    Version of Record online : 2 AUG 2008, DOI: 10.1111/j.1471-4159.2008.05604.x

  14. You have free access to this content
    The relevance of iron in the pathogenesis of Parkinson’s disease

    Journal of Neurochemistry

    Volume 118, Issue 6, September 2011, Pages: 939–957, Jeswinder Sian-Hülsmann, Silvia Mandel, Moussa B. H. Youdim and Peter Riederer

    Version of Record online : 31 JAN 2011, DOI: 10.1111/j.1471-4159.2010.07132.x

  15. Dopaminergic and non-dopaminergic pharmacological hypotheses for gait disorders in Parkinson’s disease

    Fundamental & Clinical Pharmacology

    Volume 24, Issue 4, August 2010, Pages: 407–421, David Devos, L. Defebvre and R. Bordet

    Version of Record online : 12 FEB 2010, DOI: 10.1111/j.1472-8206.2009.00798.x

  16. The effect of onset age on the clinical features of Parkinson’s disease

    European Journal of Neurology

    Volume 16, Issue 4, April 2009, Pages: 450–456, M. M. Wickremaratchi, Y. Ben-Shlomo and H. R. Morris

    Version of Record online : 27 JAN 2009, DOI: 10.1111/j.1468-1331.2008.02514.x

  17. You have free access to this content
    How should we treat a patient with early Parkinson’s disease?

    International Journal of Clinical Practice

    Volume 64, Issue 9, August 2010, Pages: 1210–1219, S. Tsouli and S. Konitsiotis

    Version of Record online : 13 JUL 2010, DOI: 10.1111/j.1742-1241.2010.02371.x

  18. Protein aggregation in Parkinson’s disease

    Acta Neurologica Scandinavica

    Volume 122, Issue s190, July 2010, Pages: 82–87, V. Gundersen

    Version of Record online : 2 JUN 2010, DOI: 10.1111/j.1600-0404.2010.01382.x

  19. You have free access to this content
    Controlling the mass action of α-synuclein in Parkinson’s disease

    Journal of Neurochemistry

    Volume 107, Issue 2, October 2008, Pages: 303–316, Changyoun Kim and Seung-Jae Lee

    Version of Record online : 7 AUG 2008, DOI: 10.1111/j.1471-4159.2008.05612.x

  20. Targeting metabolic inflammation in Parkinson’s disease: Implications for prospective therapeutic strategies

    Clinical and Experimental Pharmacology and Physiology

    Volume 39, Issue 6, June 2012, Pages: 577–585, Ming Lu and Gang Hu

    Version of Record online : 29 MAY 2012, DOI: 10.1111/j.1440-1681.2011.05650.x